Literature DB >> 9015464

Bladder cancer.

H Y Leung1, T R Griffiths, D E Neal.   

Abstract

Bladder cancer is the fourth most common cancer in England and Wales. The most common presenting symptom is macroscopic haematuria. The management options for superficial and invasive bladder cancer depend on the stage at presentation. Most superficial bladder cancers are managed by transurethral resection and cytoscopic follow-up. The prognosis for patients with invasive bladder cancer is less good. The role of chemical, radiotherapeutic and surgical intervention are discussed.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9015464      PMCID： PMC2398659          DOI： 10.1136/pgmj.72.854.719

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  33 in total

1.  Local recurrence and survival following nerve-sparing radical cystoprostatectomy.

Authors:  C B Brendler; G D Steinberg; F F Marshall; J L Mostwin; P C Walsh
Journal:  J Urol       Date:  1990-11       Impact factor: 7.450

Review 2.  Malignancies in bladder augmentations and intestinal conduits.

Authors:  R B Filmer; J R Spencer
Journal:  J Urol       Date:  1990-04       Impact factor: 7.450

3.  The epidermal growth factor receptor and the prognosis of bladder cancer.

Authors:  D E Neal; L Sharples; K Smith; J Fennelly; R R Hall; A L Harris
Journal:  Cancer       Date:  1990-04-01       Impact factor: 6.860

4.  Should pT1 transitional cell cancers of the bladder still be classified as superficial?

Authors:  P D Abel; R R Hall; G Williams
Journal:  Br J Urol       Date:  1988-09

5.  Molecular genetic alterations in superficial and locally advanced human bladder cancer.

Authors:  J C Presti; V E Reuter; T Galan; W R Fair; C Cordon-Cardo
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

6.  The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2)

Authors:  S B Malkowicz; P Nichols; G Lieskovsky; S D Boyd; J Huffman; D G Skinner
Journal:  J Urol       Date:  1990-09       Impact factor: 7.450

7.  Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).

Authors:  D A Tolley; T B Hargreave; P H Smith; J L Williams; K M Grigor; M K Parmar; L S Freedman; B M Uscinska
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25

8.  Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification.

Authors:  F Pagano; P Bassi; T P Galetti; A Meneghini; C Milani; W Artibani; A Garbeglio
Journal:  J Urol       Date:  1991-01       Impact factor: 7.450

9.  The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial.

Authors:  D G Skinner; J R Daniels; C A Russell; G Lieskovsky; S D Boyd; P Nichols; W Kern; J Sakamoto; M Krailo; S Groshen
Journal:  J Urol       Date:  1991-03       Impact factor: 7.450

10.  Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.

Authors:  C Wright; K Mellon; P Johnston; D P Lane; A L Harris; C H Horne; D E Neal
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640
View more
  3 in total

1.  Clinico-pathological features of bladder carcinoma in women in Pakistan and smokeless tobacco as a possible risk factor.

Authors:  Muhammad Rafique
Journal:  World J Surg Oncol       Date:  2005-08-05       Impact factor: 2.754

2.  Review: Application of Nanoparticles in Urothelial Cancer of the Urinary Bladder.

Authors:  Chieh-Hsiao Chen; Tzu-Min Chan; Yi-Jhen Wu; Jia-Jin Chen
Journal:  J Med Biol Eng       Date:  2015-08-11       Impact factor: 1.553

3.  circ_100984-miR-432-3p axis regulated c-Jun/YBX-1/β-catenin feedback loop promotes bladder cancer progression.

Authors:  Liang Tong; Huihui Yang; Wei Xiong; Guyu Tang; Xiongbing Zu; Lin Qi
Journal:  Cancer Sci       Date:  2021-02-10       Impact factor: 6.518
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.